Olina Ngwenya

Statistical and mathematical modelling of HIV and AIDS, effect of reverse transcriptase inhibitors and causal inference for HIV mortality.

Olina Ngwenya, 2014 .

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study

G. Maartens, Rulan Griesel, G. V. Van Zyl, 2021, AIDS.

Title Spatial heterogeneity in projected leprosy trends in India Permalink

A. Galvani, M. Ndeffo-Mbah, L. Worden, 2015 .

Accessing HIV care may lead to earlier ascertainment of comorbidities in health care clients in Khayelitsha, Cape Town

N. Tiffin, Olina Ngwenya, R. Osei-Yeboah, 2021, PLOS global public health.

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

L. Morris, M. Mendelson, G. Maartens, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spatial heterogeneity in projected leprosy trends in India

A. Galvani, M. Ndeffo-Mbah, L. Worden, 2015, Parasites & Vectors.

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial

G. Maartens, Rulan Griesel, Olina Ngwenya, 2021, Wellcome open research.

COVID-19 among adults living with HIV: Correlates of mortality in a general population in a resource-limited setting

M. Mendelson, N. Tiffin, Olina Ngwenya, 2022, medRxiv.

COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa

M. Mendelson, N. Tiffin, Olina Ngwenya, 2023, Journal of the International AIDS Society.

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks

G. Maartens, Rulan Griesel, Olina Ngwenya, 2022, Journal of acquired immune deficiency syndromes.

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial [version 1; peer review: 2 approved, 1 approved with reservations]

G. Maartens, Rulan Griesel, Olina Ngwenya, 2023 .